6 research outputs found
Percentage of respondents who recommended an anti-MRSA agent for uncomplicated CAP (N = 135) and PPE (N = 134) across a range of reported MRSA prevalence levels in their community.
<p>MRSA, methicillin-resistant <i>S. aureus</i>; CAP, community-acquired pneumonia; PPE, parapneumonic empyema.</p
Percentage of respondents who recommended clindamycin as an anti-MRSA agent for uncomplicated CAP (N = 27) and PPE (N = 117) across a range of reported clindamycin resistance levels.
<p>MRSA, methicillin-resistant <i>S. aureus</i>; CAP, community-acquired pneumonia; PPE, parapneumonic empyema.</p
Empiric antibiotic regimens recommended for uncomplicated pneumonia and PPE.
<p>PPE, parapneumonic empyema.</p><p>MRSA, methicillin-resistant <i>S. aureus</i>.</p
Recommended duration of therapy for uncomplicated CAP (N = 140) and PPE (N = 138).
<p>CAP, community-acquired pneumonia; PPE, parapneumonic empyema.</p
A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures
<p><strong>Article full
text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s40121-016-0136-8"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced content for this article</strong><br>
If you are an author of this publication and would like to provide additional
enhanced content for your article then please contact <u>[email protected]</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides</p>
<p> </p>
<p> </p>
<p> </p
Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study
<p><strong>Article full text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s40121-016-0105-2"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced content for this article</strong><br>
There are currently no enhanced features for this article. If
you are an author of this publication and would like to provide additional
enhanced content for your article then please contact <u>[email protected]</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are not limited to:</p>
<p>•
Summary Slides</p>
<p>•
Slide decks</p>
<p>•
Videos and animations</p>
<p>•
Audio abstracts</p>
<p>•
Audio slides</p>
<p> </p